Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/105071| Title: | Vaccine trials with no serious adverse reactions – estimation of upper 95% confidence intervals for likelihood of such events |
| Authors: | Grech, Victor E. Grech, Elizabeth Cuschieri, Sarah |
| Keywords: | COVID-19 vaccines -- Side effects COVID-19 (Disease) -- Vaccination -- Complications ChAdOx1 nCoV-19 AstraZeneca (Firm) |
| Issue Date: | 2022 |
| Publisher: | Wolters Kluwer |
| Citation: | Grech, V., Grech, E., & Cuschieri, S. (2022). Vaccine trials with no serious adverse reactions–estimation of upper 95% confidence intervals for likelihood of such events. Saudi Journal of Anaesthesia, 16(4), 506-507. |
| Abstract: | COVID‑19 remains a pandemic at the time of writing (July 2021) and the ultimate solution appears to be global vaccination. In trials, vaccines did not demonstrate serious side effects and only manifested transient symptoms such as fever and malaise, as well as local reactions such as pain and tenderness at the injection site, effects that continue to be observed even with ongoing mass vaccination. However, it is still possible to have serious rare side effects as millions and even billions are vaccinated. This paper will demonstrate a simple way to estimate such risks based on actual trial data and the on ongoing vaccination. [Excerpt] |
| URI: | https://www.um.edu.mt/library/oar/handle/123456789/105071 |
| Appears in Collections: | Scholarly Works - FacM&SAna |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Vaccine trials with no serious adverse reactions estimation of upper 95 percent confidence intervals for likelihood of such events 2022.pdf | 565.7 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.